Home Newsfeeds Apple To Reduce iPhone14 Plus Production After Weak Demand

Apple To Reduce iPhone14 Plus Production After Weak Demand

– Fox Business Report

byBenzinga Newsdesk

October 27, 2022

1 minute read

– Fox Business Report

Lucid Group Q3 Earnings: Revenue Miss, EPS Beat, Lowered Production Guidance, Gravity Release Date And More

By Adam Eckert

November 7, 5:38 PM

Lucid Group Inc (NASDAQ: LCID) reported third-quarter financial results Tuesday after the bell. Here's a rundown of the report and a look at what's driving shares lower after hours.

LCID

Why Canopy Growth Stock (CGC) Is Rising Again

By Henry Khederian

September 6, 10:11 AM

Canopy Growth Corp (NASDAQ: CGC) shares are trading higher by 7.6% to $0.74 Wednesday morning, driven by the recent, strong performance of the cannabis sector.

CGC

FDA Requests For Additional Monitoring For Travere Therapeutics’ Sparsentan In Rare Kidney Disease

By Vandana Singh

October 14, 10:02 AM

Following late-cycle review interactions with the FDA, Travere Therapeutics Inc (NASDAQ:TVTX) expects the previously assigned Prescription Drug User Fee Act…

TVTX

Analysts Note Medtronic’s Tummy Tuck Surgery Sales Unaffected Globally Amid Weight-Loss Treatment(s) Rush

By Vandana Singh

August 23, 12:35 PM

William Blair writes that Medtronic Plc's (NYSE: MDT) Q1 FY24 witnessed a remarkable performance cascaded to the bottom line, amplified by improved gross margins due to better pricing discipline and effective control and

ISRG

Apple To Reduce iPhone14 Plus Production After Weak Demand

Related Posts

Lucid Group Q3 Earnings: Revenue Miss, EPS Beat, Lowered Production Guidance, Gravity Release Date And More

Why Canopy Growth Stock (CGC) Is Rising Again

FDA Requests For Additional Monitoring For Travere Therapeutics’ Sparsentan In Rare Kidney Disease

Analysts Note Medtronic’s Tummy Tuck Surgery Sales Unaffected Globally Amid Weight-Loss Treatment(s) Rush